HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yutaka Ogata Selected Research

Antigens

1/2009Elevated preoperative serum carcinoembrionic antigen level may be an effective indicator for needing adjuvant chemotherapy after potentially curative resection of stage II colon cancer.
3/2002Expression of tumor rejection antigens in colorectal carcinomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yutaka Ogata Research Topics

Disease

34Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 01/2002
22Neoplasms (Cancer)
04/2021 - 01/2002
16Colonic Neoplasms (Colon Cancer)
02/2022 - 01/2003
15Neoplasm Metastasis (Metastasis)
04/2021 - 01/2003
8Carcinoma (Carcinomatosis)
02/2022 - 03/2002
7Rectal Neoplasms (Rectal Cancer)
11/2014 - 01/2002
3Adenocarcinoma
04/2021 - 01/2003
3Neutropenia
04/2016 - 04/2012
2Anorexia
04/2016 - 01/2016
2Stomatitis
02/2016 - 04/2012
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2012 - 05/2003
1Mucinous Adenocarcinoma (Mucinous Carcinoma)
02/2022
1Sigmoid Neoplasms
04/2021
1Fatigue
04/2016
1Anemia
04/2016
1Hypertension (High Blood Pressure)
02/2016
1Thrombosis (Thrombus)
02/2016
1Disease Progression
02/2016
1Diarrhea
01/2016
1Peripheral Nervous System Diseases (PNS Diseases)
08/2015
1Pain (Aches)
05/2015
1Polyps
05/2015
1Gallstones (Gallstone)
05/2015
1Stevens-Johnson Syndrome (Lyell's Syndrome)
02/2015
1Neoplasm Micrometastasis
11/2012
1Ascites
02/2007
1Stomach Neoplasms (Stomach Cancer)
02/2007
1Hydronephrosis
02/2007
1Lymphatic Metastasis
05/2006

Drug/Important Bio-Agent (IBA)

11Irinotecan (Camptosar)FDA LinkGeneric
01/2018 - 07/2007
10Bevacizumab (Avastin)FDA Link
01/2018 - 09/2008
10Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2018 - 01/2011
10Fluorouracil (Carac)FDA LinkGeneric
02/2016 - 11/2003
6Leucovorin (Folinic Acid)FDA Link
02/2022 - 01/2011
5doxifluridineIBA
11/2007 - 01/2005
4Cetuximab (Erbitux)FDA Link
09/2016 - 05/2012
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2008 - 01/2003
3UracilIBA
02/2022 - 11/2007
3Biological ProductsIBA
10/2015 - 08/2004
2TegafurIBA
02/2022 - 12/2015
2regorafenibIBA
01/2016 - 02/2015
2Messenger RNA (mRNA)IBA
10/2015 - 11/2003
2antineoplaston AS 2-1IBA
01/2014 - 03/2005
2Capecitabine (Xeloda)FDA Link
04/2013 - 01/2006
2AntigensIBA
01/2009 - 03/2002
2Thymidine PhosphorylaseIBA
07/2007 - 01/2006
2Proliferating Cell Nuclear Antigen (PCNA)IBA
01/2006 - 08/2004
2Proteins (Proteins, Gene)FDA Link
01/2006 - 08/2004
2Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA
01/2006 - 11/2003
1Carcinoembryonic AntigenIBA
04/2021
1Keratin-7 (Cytokeratin 7)IBA
04/2021
1Keratin-20 (Cytokeratin 20)IBA
04/2021
1CDX2 Transcription FactorIBA
04/2021
1ErbB Receptors (EGF Receptor)IBA
09/2016
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
04/2016
1Alanine Transaminase (SGPT)IBA
04/2016
1XELOXIBA
04/2016
1Amino AcidsFDA Link
02/2016
1trifluridine tipiracil drug combinationIBA
01/2016
1Hemoglobins (Hemoglobin)IBA
01/2016
1Calcibiotic Root Canal SealerIBA
10/2015
1gosha-jinki-ganIBA
08/2015
1antineoplaston A10 (A 10)IBA
01/2015
1phenylacetic acid (phenylacetate)FDA Link
01/2014
1phenylacetylglutamineIBA
01/2014
1BilirubinIBA
04/2013
1Tumor Biomarkers (Tumor Markers)IBA
05/2012
1Biomarkers (Surrogate Marker)IBA
07/2011
1involucrinIBA
08/2010
1Keratin-14 (Keratin 14)IBA
08/2010
1Keratin-5 (Keratin 5)IBA
08/2010
1Progesterone Receptors (Progesterone Receptor)IBA
08/2010
1Estrogen ReceptorsIBA
08/2010
1Keratin-8 (Keratin 8)IBA
08/2010
1VimentinIBA
08/2010
1Mucin-1 (CA 15-3 Antigen)IBA
08/2010
1Indicators and Reagents (Reagents)IBA
01/2009
1Cytotoxins (Cytolysins)IBA
09/2008
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
09/2008
1titanium silicide (TS-1)IBA
02/2007
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
05/2006

Therapy/Procedure

19Therapeutics
01/2020 - 01/2005
16Drug Therapy (Chemotherapy)
01/2018 - 06/2002
11Adjuvant Chemotherapy
02/2022 - 01/2002
5Combination Drug Therapy (Combination Chemotherapy)
02/2016 - 01/2011
3Colectomy
04/2021 - 01/2003
3Aftercare (After-Treatment)
01/2014 - 01/2003
2Drug Tapering
02/2016 - 04/2012
2Hepatectomy
01/2015 - 03/2008
2Chemoradiotherapy
11/2014 - 06/2013
2Proctectomy
06/2013 - 11/2009
2Lymph Node Excision (Lymph Node Dissection)
05/2006 - 01/2005
1Salvage Therapy
01/2016
1Kampo Medicine (Kampo)
08/2015
1Laparoscopic Cholecystectomy
05/2015
1Cholecystectomy
05/2015
1Analgesia
05/2015
1Radiofrequency Ablation
11/2012
1Intraperitoneal Injections
07/2011
1Gastrectomy
02/2007